Search - tctmd.com

Displaying 881 - 900 of 1310

Sort: Relevancy | Date

Presentation TCT 2014

Natural History of Vulnerable Plaque: Targets for Risk Stratification

Presenter: Valentin Fuster, Patrick W. Serruys, Peter H. Stone

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Graham A. Cassel, Hans R. Figulla, Greg L. Kaluza, Jochen Wöhrle, Peter Boekstegers

September 14, 2014

Presentation TCT 2014

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Presenter: Graham A. Cassel, Hans R. Figulla, Greg L. Kaluza, Jochen Wöhrle, Peter Boekstegers

September 14, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Petr Kala, Josef Stasek, Alec S. Vahanian, Viliam Fridrich

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Petr Kala, Josef Stasek, Alec S. Vahanian, Stanislav Juhas

September 14, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Petr Kala, Josef Stasek, Alec S. Vahanian, Michael Zelizko

September 14, 2014

Presentation TCT 2014

Case #2: Extraction of a Fractured Guidewire During NSTEMI Intervention

Presenter: Petr Kala, Josef Stasek, Alec S. Vahanian, Stanislav Juhas

September 14, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian, Pavel Cervinka

September 14, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian

September 14, 2014

Presentation TCT 2014

Case #1: Complex Patient with NSTEMI and Severe Aortic Stenosis

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian, Pavel Cervinka

September 14, 2014

Presentation TCT 2014

Emerging Funding Models and International Partnerships

Presenter: Louis A. Cannon, Casey McGlynn, Peter J. Fitzgerald

September 13, 2014

Presentation TCT 2014

Collaborative Funding Models for De-Risking Investment in Early Stage Technologies

Presenter: Louis A. Cannon, Casey McGlynn, Peter J. Fitzgerald, Dale A Wahlstrom

September 13, 2014

Presentation TCT 2014

The Venture Capital Model: Time to Revisit the Strategy?

Presenter: Louis A. Cannon, Casey McGlynn, Peter J. Fitzgerald

September 13, 2014

Presentation TCT 2014

Next-Generation Carotid Artery Stents: Are Mesh/Membrane Stents Game Changers?

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Peter A. Schneider

September 13, 2014

Presentation TCT 2014

Reverse Engineering and Region-Specific Innovation

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan

September 13, 2014

Presentation TCT 2014

Organic Innovation: Corporate Perspective

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan, Jim Barry

September 13, 2014

Presentation TCT 2014

Incubators and Accelerators

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan, Hanson S. Gifford

September 13, 2014

Presentation TCT 2014

The New MedTech Environment: Changes in the Ecosystem Impacting Technology Development

Presenter: Peter J. Fitzgerald, Frank Litvack, Chaim S. Lotan

September 13, 2014

Presentation TCT 2014

Challenges for the Cath Lab Leader: From Credentialing to Conflict Resolution

Presenter: Peter L. Duffy, Sunil V. Rao, Ehtisham Mahmud

September 13, 2014

Advertisement

Natural History of Vulnerable Plaque: Targets for Risk Stratification

How Did I Treat This Patient?

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Consensus and Take-home Messages

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #2: Extraction of a Fractured Guidewire During NSTEMI Intervention

Consensus and Take-home Messages

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #1: Complex Patient with NSTEMI and Severe Aortic Stenosis

Emerging Funding Models and International Partnerships

Collaborative Funding Models for De-Risking Investment in Early Stage Technologies

The Venture Capital Model: Time to Revisit the Strategy?

Next-Generation Carotid Artery Stents: Are Mesh/Membrane Stents Game Changers?

Reverse Engineering and Region-Specific Innovation

Organic Innovation: Corporate Perspective

Incubators and Accelerators

The New MedTech Environment: Changes in the Ecosystem Impacting Technology Development

Challenges for the Cath Lab Leader: From Credentialing to Conflict Resolution

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content